Lithium for Bipolar Disorder: What Clinicians Need to Know

Friday, June 2, 2023

2:00 PM – 3:00 PM PT

Location: Octavius 11

For patients with a history of mania, lithium is the gold standard mood stabilizer - clinicians should be experts in its use. But despite its constellation of activities, many clinicians are wary of lithium out of concern for renal and other adverse effects. This presentation will provide clinicians with the latest information on lithium’s preferred place in the treatment of bipolar patients, lithium dosing, kinetics and target serum levels, and evidence-based methods to mitigate renal dysfunction. Clinicians will also be provided information on how to track and treat polyuria, and how to manage common nonrenal adverse effects such as tremor, cognitive dulling, nausea or diarrhea, along with the latest studies supporting lithium use during breastfeeding, and new risk estimates with 1st trimester exposure during pregnancy.

Speaker(s)

Jonathan M. Meyer

Voluntary Clinical Professor of Psychiatry
University of California, San Diego
University of California, San Diego
San Diego, California
Craig Chepke, MD, DFAPA

Medical Director, Excel Psychiatric Associates; Adjunct Associate Professor of Psychiatry, Atrium Health
Excel Psychiatric Associates
Huntersville, North Carolina

Moderator(s)

Andrew D. Penn, MS, PMHNP

Clinical Professor
University of California, San Francisco, School of Nursing
University of California, San Francisco
SAN FRANCISCO, California